Literature DB >> 15578944

Role of metabolism in ocular drug delivery.

Sridhar Duvvuri1, Soumyajit Majumdar, Ashim K Mitra.   

Abstract

Metabolism is one of the primary routes of drug elimination from the body. This process comprises of mechanisms, such as oxidation and conjugation, which lead to inactivation and/or elimination from hepatic, biliary, pulmonary, renal and ocular tissues. Enzymes involved in metabolism are expressed in various tissues of the body, liver being the primary site. Studies involving ocular tissues have demonstrated the expression of several metabolic enzymes such as esterases, peptidases, ketone reductases, and CYP-450's in these tissues. These enzymes play an important role in ocular homeostasis by preventing entry and/or eliminating xenobiotics from the ocular tissues. Scientists have targeted these enzymes in drug design and delivery through prodrug derivatization. The prodrugs undergo biotransformation to the parent drug by ocular enzymatic degradation. This review examines the distribution pattern of various metabolic enzymes in the ocular tissues, their physiological role and utility in targeted prodrug delivery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15578944     DOI: 10.2174/1389200043335342

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  19 in total

Review 1.  Prodrug strategies in ocular drug delivery.

Authors:  Megha Barot; Mahuya Bagui; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Med Chem       Date:  2012-07       Impact factor: 2.745

Review 2.  Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.

Authors:  Abeer M Al-Ghananeem; Peter A Crooks
Journal:  Molecules       Date:  2007-03-08       Impact factor: 4.411

3.  [Pharmacokinetics of the anterior eye].

Authors:  K Bell; N Pfeiffer; F H Grus
Journal:  Ophthalmologe       Date:  2014-02       Impact factor: 1.059

Review 4.  Novel strategies for anterior segment ocular drug delivery.

Authors:  Kishore Cholkar; Sulabh P Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-05       Impact factor: 2.671

5.  Impacts of nanomedicines in ocular pharmacotherapy.

Authors:  Ailar Nakhlband; Jaleh Barar
Journal:  Bioimpacts       Date:  2011-06-09

6.  Tacrolimus Loaded PEG-Cholecalciferol Based Micelles for Treatment of Ocular Inflammation.

Authors:  Shallu Kutlehria; Imran Vhora; Arvind Bagde; Nusrat Chowdhury; Gautam Behl; Ketan Patel; Mandip Singh
Journal:  Pharm Res       Date:  2018-04-16       Impact factor: 4.200

7.  Intravitreal kinetics of hesperidin, hesperetin, and hesperidin G: effect of dose and physicochemical properties.

Authors:  Ramesh Srirangam; Ketan Hippalgaonkar; Soumyajit Majumdar
Journal:  J Pharm Sci       Date:  2012-01-06       Impact factor: 3.534

Review 8.  Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.

Authors:  Prit Lakhani; Akash Patil; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2018-11-08       Impact factor: 2.671

9.  Hypoxia alters ocular drug transporter expression and activity in rat and calf models: implications for drug delivery.

Authors:  Rajendra S Kadam; Preveen Ramamoorthy; Daniel J LaFlamme; Timothy A McKinsey; Uday B Kompella
Journal:  Mol Pharm       Date:  2013-05-22       Impact factor: 4.939

10.  Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye.

Authors:  Silvia Pescina; Fabio Sonvico; Adryana Clementino; Cristina Padula; Patrizia Santi; Sara Nicoli
Journal:  Pharmaceutics       Date:  2021-06-09       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.